Literature DB >> 19465641

Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells.

Subramanya Hegde1, Ewa Jankowska-Gan, Drew A Roenneburg, Jose Torrealba, William J Burlingham, Jenny E Gumperz.   

Abstract

NKT cells have been shown to promote peripheral tolerance in a number of model systems, yet the processes by which they exert their regulatory effects remain poorly understood. Here, we show that soluble factors secreted by human NKT cells instruct human peripheral blood monocytes to differentiate into myeloid APCs that have suppressive properties. NKT instructed monocytes acquired a cell surface phenotype resembling myeloid DCs. However, whereas control DCs that were generated by culturing monocytes with recombinant GM-CSF and IL-4 had a proinflammatory phenotype characterized by the production of IL-12 with little IL-10, NKT-instructed APCs showed the opposite cytokine production profile of high IL-10 with little or no IL-12. The control DCs efficiently stimulated peripheral blood T cell IFN-gamma secretion and proliferation, whereas NKT-instructed APCs silenced these T cell responses. Exposure to NKT cell factors had a dominant effect on the functional properties of the DCs, since DCs differentiated by recombinant GM-CSF and IL-4 in the presence of NKT cell factors inhibited T cell responses. To confirm their noninflammatory effects, NKT-instructed APCs were tested in an in vivo assay that depends on the activation of antigen-specific human T cells. Control DCs promoted substantial tissue inflammation; however, despite a marked neutrophilic infiltrate, there was little edema in the presence of NKT-instructed APCs, suggesting the inflammatory cascade was held in check. These results point to a novel pathway initiated by NKT cells that can contribute to the regulation of human antigen-specific Th1 responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465641      PMCID: PMC2752012          DOI: 10.1189/jlb.0209059

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  63 in total

1.  Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.

Authors:  Yi-Guang Chen; Caroline-Morgane Choisy-Rossi; Thomas M Holl; Harold D Chapman; Gurdyal S Besra; Steven A Porcelli; Daniel J Shaffer; Derry Roopenian; S Brian Wilson; David V Serreze
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 2.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  Innate immunity: NKT cells in the spotlight.

Authors:  Luc Van Kaer; Sebastian Joyce
Journal:  Curr Biol       Date:  2005-06-07       Impact factor: 10.834

4.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

5.  Recognition of bacterial glycosphingolipids by natural killer T cells.

Authors:  Yuki Kinjo; Douglass Wu; Gisen Kim; Guo-Wen Xing; Michael A Poles; David D Ho; Moriya Tsuji; Kazuyoshi Kawahara; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

6.  Trans vivo analysis of human delayed-type hypersensitivity reactivity.

Authors:  L Carrodeguas; C G Orosz; W J Waldman; D D Sedmak; P W Adams; A M VanBuskirk
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

7.  Lysosomal glycosphingolipid recognition by NKT cells.

Authors:  Dapeng Zhou; Jochen Mattner; Carlos Cantu; Nicolas Schrantz; Ning Yin; Ying Gao; Yuval Sagiv; Kelly Hudspeth; Yun-Ping Wu; Tadashi Yamashita; Susann Teneberg; Dacheng Wang; Richard L Proia; Steven B Levery; Paul B Savage; Luc Teyton; Albert Bendelac
Journal:  Science       Date:  2004-11-11       Impact factor: 47.728

8.  Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Authors:  Jonathan D Silk; Ian F Hermans; Uzi Gileadi; Tsung Wen Chong; Dawn Shepherd; Mariolina Salio; Bini Mathew; Richard R Schmidt; Sarah Jane Lunt; Kaye J Williams; Ian J Stratford; Adrian L Harris; Vincenzo Cerundolo
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

Authors:  A Lehuen; O Lantz; L Beaudoin; V Laloux; C Carnaud; A Bendelac; J F Bach; R C Monteiro
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  21 in total

1.  Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.

Authors:  Isabel Sada-Ovalle; Markus Sköld; Tian Tian; Gurdyal S Besra; Samuel M Behar
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

2.  Editorial: NKT cells: to suppress or not to suppress, that is the question.

Authors:  Jeff J Subleski; John R Ortaldo
Journal:  J Leukoc Biol       Date:  2009-10       Impact factor: 4.962

3.  Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands.

Authors:  Subramanya Hegde; Jennifer L Lockridge; Yusof A Becker; Shidong Ma; Shannon C Kenney; Jenny E Gumperz
Journal:  J Autoimmun       Date:  2011-04-12       Impact factor: 7.094

4.  Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.

Authors:  J A Sullivan; E Jankowska-Gan; L Shi; D Roenneburg; S Hegde; D S Greenspan; D S Wilkes; L C Denlinger; W J Burlingham
Journal:  Am J Transplant       Date:  2014-05-27       Impact factor: 8.086

5.  NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.

Authors:  Stephen R Mattarollo; Michelle Yong; Christina Gosmann; Allison Choyce; Dora Chan; Graham R Leggatt; Ian H Frazer
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

Review 6.  Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.

Authors:  Subramanya Hegde; Lisa Fox; Xiaohua Wang; Jenny E Gumperz
Journal:  Immunology       Date:  2010-05-11       Impact factor: 7.397

7.  A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist.

Authors:  Andrew J Wiemer; Subramanya Hegde; Jenny E Gumperz; Anna Huttenlocher
Journal:  J Immunol       Date:  2011-09-07       Impact factor: 5.422

8.  Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

Authors:  Kyle K Payne; Christine K Zoon; Wen Wan; Khin Marlar; Rebecca C Keim; Mehrab Nasiri Kenari; A Latif Kazim; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2013-10-25       Impact factor: 4.872

9.  Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients.

Authors:  L D Haynes; E Jankowska-Gan; A Sheka; M R Keller; M P Hernandez-Fuentes; R I Lechler; V Seyfert-Margolis; L A Turka; K A Newell; W J Burlingham
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

10.  iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.

Authors:  Nicholas J Hess; Nikhila S Bharadwaj; Elizabeth A Bobeck; Courtney E McDougal; Shidong Ma; John-Demian Sauer; Amy W Hudson; Jenny E Gumperz
Journal:  Life Sci Alliance       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.